BNTX (BioNTech Inc.) Net Profit

BNTX (BioNTech) - company brandmark

The financial performance dynamics of BioNTech SE (BNTX) clearly demonstrate a profitability trend where the -1.95 metric determines the status of the profit parameter. BioNTech SE (BNTX) is optimizing mRNA drug logistics through modern supply chains to maintain high margins. Business development relies on the success of clinical trials and vaccine demand, as well as the acquisition of AI startups to accelerate its own R&D processes.

BNTX (BioNTech SE) Net Profit history from 07/04/2022 to 10/29/2026

Analytical breakdowns and data insights for company BioNTech (BNTX)

- price and consensus price forecast:
Stock Quotes BioNTech Pharma|BNTX - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization BioNTech Pharma|BNTX - Real Price to Acquire Entire Company
- book capitalization data:
Accounting Value of a Share BioNTech|BNTX - Book Capitalization|Market Capitalization to Book Value biontech.de|BNTX - Aggregate Company Assets
- debt and solvency information:
Total Debt to Equity Ratio BioNTech SE|BNTX - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio BioNTech Inc.|BNTX - Company Total Debt|Debts to Book Capitalization BioNTech Pharma|BNTX - Company Long-Term Debt|Company Short-Term Indebtedness BioNTech|Immediate Liquidity biontech.de
- net income and valuation multiples indicators:
BNTX - Net Profit
Summary company analysis:BioNTech SE
Core merchandise of BioNTech Group

Profit measures the final financial result net of all operating and tax expenses, determining the real efficiency of the business. For BioNTech SE (BNTX), this metric reflects the ability to monetize mRNA patents and capitalize on accumulated reserves. By analyzing the company's profit, an investor assesses the pace of the transition from COVID vaccines to cancer therapy. Profit dynamics confirm the resilience of the unique immune programming platform. Stable growth of this metric makes the asset attractive for a long-term portfolio.

Main competitors

Net Income argenx BVBA|ABVX (Abivax S.A.) - Net Profit|Net Profit admabiologics.com|Net Income PTGX (Protagonist)|IMVT (Immunovant Inc) - Final Profit|Net Profit KNSA (Kiniksa Pharmaceuticals Ltd)|Net Financial Result Grifols Biemat (GRFS)|ADPT - Company Net Income|celldex.com (CLDX) - Net Income|Aurinia Pharmaceuticals Inc. (AUPH) - Company Net Income|Net Income BioCryst Pharmaceuticals, Inc.|Net Income VERA|Net Profit Dianthus Corp|Company Net Income Pharvaris N.V. (PHVS)|AbCellera Biologics Inc. - Company Profit|Net Profit TRML (Tourmaline Bio)|Precigen Inc (PGEN) - Company Net Income|Pharming - Net Profit|NKTR: Company Net Income|UPB: Net Profit|ZBIO - Net Financial Result|Company Net Income Immunome|Company Net Income Gossamer Bio Inc GOSS|Company Net Income KalVista Pharmaceuticals Inc (KALV)|Septerna Pharma - Company Profit|Pieris Pharmaceuticals - Net Income|Profit After Payment of Taxes SVRA (savarapharma.com)|Rigel Pharmaceuticals, Inc. - Net Profit|Company Net Income AnaptysBio Inc|ATXS: Net Profit|Net Income enGene Corp|RAPT (RAPT Therapeutics, Inc.) - Net Profit|JBIO: Final Profit|Net Income ACRS (Aclaris Therapeutics, Inc.)|KYTX (Kyverna Therapeutics Inc.) - Final Profit|Company Net Income Tiziana Life Sciences PLC TLSA|Net Financial Result Cabaletta Bio Inc (CABA)|Ventyx Biosciences - Net Profit|Company Net Income theratech.com|AVTX: Net Profit|ELDN (Eledon Pharmaceuticals Inc.) - Company Net Income|Company Net Income Agenus Inc|Company Profit CLYM (Climb Bio, Inc)|Net Income ZURA (Zura Bio Limited)|Profit After Payment of Taxes ATYR|Adagene Inc. - Net Income|IMA: Company Profit|STTK - Company Net Income|Profit After Tax EQ|CNTB: Net Profit|Immunic - Final Profit|ATRA (Atara Biotherapeutics, Inc.) - Net Profit|Net Profit InflaRx GmbH|Company Net Income X4 Pharma (XFOR)|ACET (adicetbio.com) - Final Profit|Company Net Income Celularity CELU|INMB - Net Income|Barinthus Biotherapeutics plc - Net Profit|KZR - Net Profit|SABS (SAB Biotherapeutics, Inc) - Net Income|Akari Therapeutics, Plc - Final Profit|ENLV (Enlivex Therapeutics Ltd) - Net Profit|Q32 Bio Corp (QTTB) - Net Financial Result|Company Net Income GeoVax (GOVX)|Net Income Edesa Biotech Inc EDSA|Company Net Income iBio Corp IBIO|CARM - Net Income|XTLB: Net Income|BOLT - Net Profit|hcwbiologics.com (HCWB) - Company Net Income|Company Profit APVO|AIM (AIM ImmunoTech) - Net Profit|Company Net Income Aditxt Corp ADTX|Net Profit GRI|Company Net Income XRTX (xortx.com)|Net Profit HIND (Vyome Holdings)|Net Financial Result Revelation Biosciences Inc (REVB)|INDP - Company Net Income|Company Net Income BiondVax Pharmaceuticals|calcimedica.com (CALI) - Company Net Income|Company Profit AFMD|Net Income ALLK|HOOK (HOOKIPA) - Profit After Payment of Taxes|Net Profit IGMS|ITOS - Company Net Income|Net Profit OCEA (Ocean Biomedical, Inc.)|TCBP - Net Income|Third Harmonic Bio, Inc. - Net Profit